Theranostics 2018; 8(22):6350-6351. doi:10.7150/thno.31741

Erratum

MicroRNA-647 targets SRF-MYH9 axis to suppress invasion and metastasis of gastric cancer: Erratum

Gengtai Ye1*, Kunzhai Huang1†*, Jiang Yu1*, Liying Zhao1, Xianjun Zhu1‡, Qingbin Yang1, Wende Li2, Yuming Jiang1, Baoxiong Zhuang1, Hao Liu3, Zhiyong Shen1, Da Wang1, Li Yan1, Lei Zhang1, Haipeng Zhou1, Yanfeng Hu1, Haijun Deng1, Hao Liu1 Corresponding address, Guoxin Li1 Corresponding address, Xiaolong Qi1 Corresponding address

1. Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangdong Provincial Engineering Technology Research Center of Minimally Invasive Surgery, Guangzhou, 510515 China;
2. Guangdong Key Laboratory of Laboratory Animal, Guangdong Laboratory Animal Monitoring Institute, Guangzhou 510663, China;
3. Leder Human Biology and Translational Medicine, Biology and Biomedical Sciences, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115.
* These authors contributed equally to this work
† Present address: Department of General Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, 361003 China.
‡ Present address: Department of General Surgery, Panyu Central Hospital, Guangzhou, 511400 China

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Ye G, Huang K, Yu J, Zhao L, Zhu X, Yang Q, Li W, Jiang Y, Zhuang B, Liu H, Shen Z, Wang D, Yan L, Zhang L, Zhou H, Hu Y, Deng H, Liu H, Li G, Qi X. MicroRNA-647 targets SRF-MYH9 axis to suppress invasion and metastasis of gastric cancer: Erratum. Theranostics 2018; 8(22):6350-6351. doi:10.7150/thno.31741. Available from http://www.thno.org/v08p6350.htm

Corrected-article in Theranostics, Volume 7, 3338

 

In our paper [1], Figure 1 should be corrected as follows.

 Figure 1 

MiR-647 is downregulated in gastric cancer tissues and associated with the migration and invasion of gastric cancer cells. (A) Expression of miR-647 was determined by qPCR in 109 human gastric cancer tissues, which was normalized against an endogenous U6 RNA control. ***p<0.001. (B) Relative miR-647 levels of GC and normal tissues measured by qPCR were shown using pie chart and waterfall plot. The fold change of relative miR-647 expression (T/N) >2 or <1/2 was defined as significant. For waterfall plot, the fold change of relative miR-647 expression (log2[T/N]) >1 or <-1 was defined as significant. (C) The relationship between miR-647 expression and clinical stages, lymph node-metastasis or local invasion. *p<0.05; **p<0.01. (D) Expression of miR-647 in 5 normal human gastric mucosa tissues, 5 GC cell lines and 3 colorectal cancer cell lines was analyzed by qPCR. (E and F) Expression of miR-647 in transfected MGC 80-3, MKN45 and AGS cell lines were analyzed by qPCR. ***p<0.001. (G and H) The 3D migration and invasion changes of different MGC 80-3 cells were tested using transwell chamber migration assay and invasion assay. Cell 2D migration was tested using monolayer wound healing assay. ***p<0.001.

Theranostics Image (Click on the image to enlarge.)

References

1. Ye G, Huang K, Yu J, Zhao L, Zhu X, Yang Q, Li W, Jiang Y, Zhuang B, Liu H, Shen Z, Wang D, Yan L, Zhang L, Zhou H, Hu Y, Deng H, Liu H, Li G, Qi X. MicroRNA-647 Targets SRF-MYH9 Axis to Suppress Invasion and Metastasis of Gastric Cancer. Theranostics. 2017;7(13):3338-3353 doi:10.7150/thno.20512

Author contact

Corresponding address Corresponding authors: Xiaolong Qi, Guoxin Li & Hao Liu, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangdong Provincial Engineering Technology Research Center of Minimally Invasive Surgery; Tel.: +86 20 61641681/ fax: +86 20 61641683; Xiaolong Qi, E-mail: qixiaolong163.com; Guoxin Li, E-mail: gzliguoxincom; Hao Liu, E-mail: liuhaofbicom


Published 2018-12-1